In Profile / Zealand Pharma's New Obesity Focus Leads to 63% Jump in Market Value
After transitioning from a fledgling biotech to a mature commercial-stage company on the back of its first approval, Zealand Pharma was hit with the challenges of commercialisation and the disappointing…